Saturday 17 October 2026
Export QTI’s income statement to Excel — free account
QT Imaging Holdings, Inc.
QTI Healthcare Medical Devices
QT Imaging Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.9 million, up 287.9% from fiscal 2024. In the quarter to June 2026, revenue grew 103.2%, EPS fell 78.6%, free cash flow fell 236.3% and total debt rose 286.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.41
0.03
+1.26%
Follow QTI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.28 | 3.57 | 3.38 | 29.63 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(12.48) | (22.17) | (20.60) | (387.75) | |
P/B ratio |
26.88 | 21.32 | 9.92 | 0.00 | |
Price to Tangible BV |
27.41 | 21.57 | 9.98 | 0.00 | |
EV/Sales |
2.45 | 3.50 | 3.07 | 30.28 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(5.19) | (8.74) | (6.48) | (49.14) | |
EV/FCF |
(5.08) | (8.60) | (6.35) | (48.41) | |
Quick Ratio |
1.93 | 1.56 | 2.06 | 0.39 | |
Current Ratio |
3.10 | 2.49 | 2.81 | 0.89 | |
Net Debt/EBITDA |
(2.34) | 0.73 | 8.58 | (4.62) | |
Debt/Assets |
49.92% | 23.86% | 19.93% | 75.83% | |
Debt/Equity |
6.81 | 1.38 | 0.71 | (1.01) | |
Asset Turnover |
1.25 | 1.38 | 1.30 | 1.20 | |
Operating CF/Net income |
0.44 | 1.07 | 2.24 | 0.19 | |
Capex/Depreciation |
(8.29) | (0.85) | (4.98) | 0.01 | |
Interest Coverage |
(2.50) | (2.53) | (0.70) | (2.93) | |
Research and Development Expense of Revenue |
21.84% | 26.40% | 15.03% | 22.39% | |
Selling, General and Administrative Expense of Revenue |
44.38% | 50.49% | 31.39% | 60.02% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
8.98% | 5.83% | 3.41% | 4.74% | |
Graham Net Nets |
0.02 | 0.04 | 0.09 | (0.03) | |
Graham Number |
0.00 | 0.00 | 0.00 | 7.35 | |
Earnings Yield |
(38.57%) | (21.12%) | (35.90%) | (7.16%) | |
Free Cash Flow Yield |
(21.10%) | (11.38%) | (14.30%) | (2.11%) | |
Revenue per Share |
0.50 | 0.47 | 0.79 | 0.44 | |
Operating CF per Share |
(0.33) | (0.26) | (0.30) | (0.09) | |
Capex per Share |
(0.01) | 0.00 | (0.01) | 0.00 | |
Free Cash Flow per Share |
(0.34) | (0.27) | (0.30) | (0.09) | |
Cash per Share |
0.74 | 0.50 | 1.00 | 0.18 | |
Shareholders Equity per Share |
0.15 | 0.28 | 0.62 | (0.95) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.15 | 0.28 | 0.62 | (0.95) | |
Free Cash Flow |
(5.01) | (3.67) | (3.18) | (0.88) | |
Working Capital |
19.92 | 12.67 | 14.22 | (1.45) | |
Capital Expenditures |
(0.17) | (0.02) | (0.08) | 0.00 | |
Net Current Asset Value |
1.04 | 2.97 | 5.52 | (9.91) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.00 | 0.01 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
5.53 | 4.57 | 2.92 | 1.75 | |
Average Payables |
2.30 | 1.90 | 2.19 | 1.39 | |
Average Inventory |
6.55 | 4.85 | 4.08 | 4.21 | |
Average Assets |
21.13 | 16.45 | 14.55 | 9.54 | |
Average Common Equity |
0.96 | (8.20) | (1.55) | (9.36) |
Columns are period end dates